来自德国的现实世界证据:在电子健康记录衍生的瘤科队列中进行代表性分析和死亡终点验证
Blythe Adamson1, Sascha van Boemmel-Wegmann2, Elsie Horne3
1Flatiron Health, New York, NY, USA. badamson@flatiron.com.
BMC cancer
|January 10, 2026
概括
现在可以从德国电子健康记录中获得高质量的现实数据,用于乳腺,肺部和结直肠癌研究. 这些代表性瘤科队伍已经验证了死亡终点,使得强有力的现实世界证据产生.
科学领域:
- 在瘤学瘤学.
- 现实世界数据 (RWD)
- 医疗信息学 医疗信息学
背景情况:
- 在德国,高质量的现实世界数据 (RWD) 对于瘤学研究的可用性有限.
- 电子健康记录 (EHR) 衍生数据集提供了潜力,但需要对代表性和数据质量进行验证.
- 需要可靠的RWD来支持临床决策和研究在德国瘤学.
研究的目的:
- 为了描述德国的EHR衍生的瘤队列.
- 评估这些队列的代表性与国家基准相比.
- 为了验证可靠的真实世界证据 (RWE) 生产的死亡终点.
主要方法:
- 来自德国Flatiron健康研究数据库 (2016-2024) 的非识别EHR数据的分析.
- 包括患有乳腺癌,非小细胞肺癌 (NSCLC) 或结直肠癌 (CRC) 的成年患者.
- 人口和临床特征与国家基准的比较;与德国癌症登记处对死亡率数据的验证.
主要成果:
- 乳腺 (n=1,305),NSCLC (n=866) 和CRC (n=774) 的不同队列的特征,详细的人口统计和疾病特征.
- 密切调整队列特征与所有癌症类型的国家基准.
- 验证的死亡终点具有高灵敏度 (87.7%),特异性 (91.7%) 和时间准确性 (98.8%).
结论:
- 德国EHR衍生的癌症患者队列代表了国家人口.
- 经过验证的死亡终点支持使用这些数据集用于RWE生成.
- 这些验证的队列是德国瘤学研究的宝贵资源.
更多相关视频
12:23Multi-modal Imaging of Angiogenesis in a Nude Rat Model of Breast Cancer Bone Metastasis Using Magnetic Resonance Imaging, Volumetric Computed Tomography and Ultrasound
Published on: August 14, 2012
14.8K
14:15Multicolor 3D Printing of Complex Intracranial Tumors in Neurosurgery
Published on: January 11, 2020
7.6K
相关概念视频
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Introduction to Epidemiology
Epidemiology, known as the cornerstone of public health, involves studying the distribution and determinants of health-related events in defined populations and applying these insights to control health issues. This is essential for understanding how diseases spread, identifying populations at greater risk, and implementing measures to control or prevent outbreaks. Epidemiology addresses not only infectious diseases but also non-communicable conditions like cancer and cardiovascular disease,...
Actuarial Approach
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Kaplan-Meier Approach
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
Comparing the Survival Analysis of Two or More Groups
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and Cox...
Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
